Skip to content

Japt.gr

Hellenic Atherosclerosis Society

HOME
ABOUT
- SCOPE
- EDITORIAL BOARD
CURRENT ISSUE
ARCHIVES
FOR AUTHORS
SUBMIT MANUSCRIPT
CONTACT

Menu

Search for:

PCSK9 administration ameliorates non alcoholic fatty disease in patients with heterozygous familial hyperlipidemia

Aikaterini Dimakopoulou, Georgios Sfikas, Vasilios Athyros

Post navigation

← A case of uncommon cause…

Yogurt enriched with a natural… →

Search for:

CURRENT ISSUE

Apolipoprotein A2 reduces the levels of circulating triglyceride-rich lipoproteins, an effect blocked by apolipoprotein E

The synergistic effect of EPA and DHA with cyclooxygenase-1 inhibitors on platelet aggregation

Association between screen-time use and cardiometabolic-related lifestyle characteristics, in Greek young adults

Obesity is a disease: A Consensus Report by the Alliance to Fight Obesity in Greece

Keywords

acute coronary syndrome (4) Arterial hypertension (4) arterial stiffness (5) Atherosclerosis (20) blood pressure (4) cardiovascular disease (25) cardiovascular diseases (6) cardiovascular events (3) Cardiovascular risk (6) childhood obesity (3) coronary artery disease (4) coronary heart disease (4) COVID-19 (4) diabetes mellitus (9) diet (6) dyslipidemia (14) empagliflozin (3) ezetimibe (4) Familial hypercholesterolemia (4) Heart failure (5) hypertension (8) inflammation (10) lipoproteins (4) longevity (3) Mediterranean diet (8) metabolic syndrome (7) morbidity (3) mortality (8) NAFLD (3) non-alcoholic fatty-liver disease (4) obesity (9) PCSK9 (3) PCSK9 inhibitors (4) physical activity (4) platelets (8) primary prevention (3) pulse wave velocity (3) rosuvastatin (3) smoking (3) statins (14) stroke (3) thrombin (3) thrombosis (4) treatment (5) type 2 diabetes mellitus (4)

Journal of Atherosclerosis Prevention and Treatment ©2023

A SiteOrigin Theme